<DOC>
	<DOCNO>NCT00382538</DOCNO>
	<brief_summary>Mid-second trimester medical termination pregnancy require admission hospital length time take woman abort . The current protocol BMC use intra-amniotic digoxin injection day prior admission . The following day , woman admit give sequential dos misoprostol delivery occurs . The average length time first dose misoprostol delivery 12 hour , require woman stay overnight . This randomized , placebo-controlled , double-blinded study design determine whether add mifepristone significantly reduce induction interval time ( time start first misoprostol delivery ) require second trimester termination .</brief_summary>
	<brief_title>Mifepristone Mid-Trimester Termination Pregnancy</brief_title>
	<detailed_description>This randomize , placebo-controlled , double-blinded study . Allocation Method : Women randomize use computer-run random number table . Tablets place capsule pharmacy accord randomization chart . Blinding : Subjects receive capsule contain either 200 mg mifepristone 250 mg Vitamin C. Neither researcher aware medication receives . Outcomes : The primary outcome measure mean interval first misoprostol dose fetal expulsion . Secondary outcome include proportion woman deliver within 24 hour first dose misoprostol proportion woman complete delivery require additional treatment retain placenta . We also compare amount pain medication use , well length hospital stay two group . Inclusion criterion Inclusion criterion : · Need second trimester induction termination pregnancy · Gestational age 18-23 week · At least 18 year age 16 year old parental consent No medical contraindication use digoxin misoprostol purpose induce abortion . · Able willing give inform consent English Spanish Exclusion criterion Exclusion criterion : · Known allergy mifepristone , misoprostol prostaglandin · Pre-existing intrauterine fetal demise · Premature preterm rupture membrane · IUD place · History chronic adrenal failure , porphyria ; concurrent long-term corticosteroid treatment Unable unwilling give inform consent English Spanish Involvement study follow : study day number one , patient undergo ultrasound-guided amniocentesis intra-amniotic injection digoxin regardless entry study . Study patient randomize treatment placebo group , receive one two similar-looking tablet contain allocated medication . The tablet swallow clinic . The patient , researcher care provider blind group assignment . All patient return hospital day digoxin injection induction . From point , treatment woman enrol enrolled study identical ; admit hospital induction termination begin use initial 400mcg misoprostol buccally . The initial dose follow 200 mcg misoprostol every six hour delivery successful 24 hour pass without delivery . Less 5 % woman require 24 hour induction , approximately 15 % require extraction placenta pas spontaneously fetus . The subject enrol differ termination patient regard follow : 1. number appointment time require hospital 2. use intra-amniotic digoxin 3. termination method ; misoprostol , 400 mg , follow 200 mg every 6 hour 4. pain medication administration ( PCA narcotic ) 5 . Medical evaluation need use method complete abortion 24 hour elapse first misoprostol dose without delivery . Analytic Plan : The primary outcome length induction interval termination . The Kaplan-Meier procedure utilized create survival curve analysis induction delivery interval time . Demographic data group also compare assure difference group . Chi -square analysis use dichotomous variable t-tests continuous variables.Study Size Power : A power calculation perform time induction delivery use significant value 0.05 power 80 % use survival analysis power formula . We use previous data estimate mean time induction estimate likely delta ( difference two treatment group ) 35 % . The number patient need group use calculation 32 , therefore total number need 64 .</detailed_description>
	<mesh_term>Mifepristone</mesh_term>
	<criteria>16 year age able give inform consent English Spanish Requesting termination pregnancy Under 16 year age rupture membrane intrauterine death</criteria>
	<gender>Female</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>October 2008</verification_date>
	<keyword>mifepristone</keyword>
	<keyword>induction</keyword>
	<keyword>abortion</keyword>
	<keyword>injection , intra-amniotic</keyword>
</DOC>